- Home
- IHRT vs ATXS Comparison
IHRT vs ATXS Comparison
Compare IHRT & ATXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IHRT | ATXS |
|---|---|---|
| Founded | 1974 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Broadcasting | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 623.2M | 732.4M |
| IPO Year | 2019 | 2015 |
Fundamental Metrics
Financial Performance| Metric | IHRT | ATXS |
|---|---|---|
| Price | $3.94 | $13.00 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 6 |
| Target Price | $4.50 | ★ $24.33 |
| AVG Volume (30 Days) | ★ 1.2M | 901.5K |
| Earning Date | 02-26-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,856,033,000.00 | $706,000.00 |
| Revenue This Year | $1.96 | N/A |
| Revenue Next Year | $5.62 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 1.39 | N/A |
| 52 Week Low | $0.95 | $3.56 |
| 52 Week High | $5.44 | $13.29 |
Technical Indicators
Market Signals| Indicator | IHRT | ATXS |
|---|---|---|
| Relative Strength Index (RSI) | 43.70 | 56.70 |
| Support Level | $3.88 | $12.73 |
| Resistance Level | $4.19 | $13.29 |
| Average True Range (ATR) | 0.19 | 0.18 |
| MACD | -0.08 | -0.02 |
| Stochastic Oscillator | 9.30 | 57.81 |
Price Performance
Historical ComparisonAbout IHRT iHeartMedia Inc.
iHeartMedia Inc is a United States-based audio media company. The company operates through the segments of the Multiplatform Group, the Digital Audio Group, and the Audio & Media Services Group. The company derives prime revenue from the Multiplatform Group segment which includes the company's Broadcast radio, Networks and Sponsorships, and Events businesses. The Digital Audio Group segment includes all of the company's digital businesses, including podcasting; and the Audio & Media Services Group includes Katz Media Group, a full-service media representation business, and RCS Sound Software, a provider of scheduling and broadcast software and services.
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.